Results 181 to 190 of about 4,257 (203)
Some of the next articles are maybe not open access.
P1289 Candida kefyr: a new emerging pathogen?
International Journal of Antimicrobial Agents, 2007S. Agudo +7 more
openaire +1 more source
Microbial drug resistance (Larchmont, N.Y.), 2018
Currently, echinocandins are first-line drugs for treatment of invasive candidiasis. However, data on how serum influences killing activity of echinocandins against uncommon Candida species are limited. Therefore, the killing activity of micafungin in RPMI-1640 and in 50% serum was compared against Candida guilliermondii, Candida lusitaniae, and ...
Qasem, Saleh +6 more
openaire +1 more source
Currently, echinocandins are first-line drugs for treatment of invasive candidiasis. However, data on how serum influences killing activity of echinocandins against uncommon Candida species are limited. Therefore, the killing activity of micafungin in RPMI-1640 and in 50% serum was compared against Candida guilliermondii, Candida lusitaniae, and ...
Qasem, Saleh +6 more
openaire +1 more source
Development and regulation of single- and multi-species Candida albicans biofilms
Nature Reviews Microbiology, 2017Megha Gulati +2 more
exaly
Systemic candidiasis by Candida kefyr: Case series from Pakistan
Journal of Medical Case Reports and Case Series, 2023openaire +1 more source
Candida albicans morphogenesis and host defence: discriminating invasion from colonization
Nature Reviews Microbiology, 2011Neil A R Gow +2 more
exaly
Candida albicans cell-type switching and functional plasticity in the mammalian host
Nature Reviews Microbiology, 2016Suzanne M Noble
exaly
Genetic control of Candida albicans biofilm development
Nature Reviews Microbiology, 2010Aaron P Mitchell
exaly
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus
Nature Reviews Microbiology, 2006Neeraj Chauhan
exaly